MedShape closes $11 million in new financing

NewsGuard 100/100 Score

MedShape, Inc., the industry leader in shape memory orthopedic devices, today announced the closing of $11 million in new financing. The investment will help drive further development and commercialization of pipeline products, including the full market release of the Eclipse Soft Tissue Anchor, MedShape's newest shape memory fixation device for soft tissue repair.

"This latest round of financing represents another significant milestone as MedShape continues its growth in the joint fusion and soft tissue repair segments," said Kurt Jacobus, CEO of MedShape. "The launch of Eclipse indicates the company's continued dedication towards advancing orthopedics by developing innovative devices using shape memory technology."

Made out of MedShape's proprietary PEEK (polyether ether ketone) Altera®, Eclipse features a non-rotational deployment technique that allows surgeons to better replicate native soft tissue anatomy and functionality. The two-part sheath-and-bullet design provides a simplified insertion and improved fixation strength compared to traditional tenodesis screws. Available in 4-9 mm diameters and 10-20 mm lengths, Eclipse accommodates numerous anatomies in tenodesis and tendon transfer procedures. PEEK Altera is biocompatible, biostable, radiolucent and MRI safe.

MedShape received FDA 510(k) clearance for Eclipse in March 2013. Since August 2013, Eclipse has been under a controlled market release, available to a select group of surgeons. The first clinical use occurred on August 5, 2013 with Dr. Grant Padley successfully performing a proximal biceps repair at Arizona Spine and Joint Hospital in Mesa, AZ. In addition, Eclipse has been successfully used in hand, knee, foot and ankle soft tissue reconstruction procedures.

"I prefer the Eclipse device over the implant I previously used for its ease of use," said Dr. Padley. "Unlike traditional tenodesis devices that can rotate and lacerate the soft tissue, Eclipse's sheath expansion method gives me the ability to place the soft tissue in the prepared bone tunnel and easily maintain the desired position throughout the procedure."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Initial high-risk antibody profile for antiphospholipid syndrome tends to remain high in pediatric patients, study finds